IGF1 and type 2 diabetes mellitus: To this end, a mouse derived colon cancer cell line—MC38 cells with insulin/IGF-1 treatment and a mouse spontaneous T2DM model with tumor allografts were used to mimic the T2DM environment in vitro and in vivo.